Press "esc" to clear
Go to Advanced Search

Showing results

110 of 1478
Chatterjee.jpg

Article ID: 705620

With a Focus on High-Risk Patients, SLU Researcher Eyes Eliminating TB for Good

Saint Louis University Medical Center

A focus on high-risk tuberculosis patients may be the answer to stalled progress in stamping out the illness in the United States.

Released:
18-Dec-2018 12:05 PM EST

Article ID: 705595

FSU Researchers Identify Ways Breast Cancer Avoids Immune System Detection

Florida State University

Researchers analyzed data from more than 1,000 breast cancer patients and found that breast cancer behaves differently than other cancers that are currently treated with immunotherapy. They identified seven clusters of breast cancer patients based on the immune evasion mechanisms that breast cancer uses to avoid detection.

Released:
18-Dec-2018 9:00 AM EST
Immune-cell-large.jpg

Article ID: 705402

The “Greying” of T Cells

Harvard Medical School

Research in mouse cells identifies defective metabolic pathway in aging immune T cells. The pathway is critical for switching T cells from dormancy into illness-fighting mode. In experiments, researchers restored lagging T-cell function by adding small-molecule compounds. Findings suggest possible mechanism behind weakened immunity common in the elderly.

Released:
13-Dec-2018 11:15 AM EST
2018Dr.MatthiasvonHerrath.jpg

Article ID: 705327

Dr. Matthias von Herrath named world’s leading type 1 diabetes expert

La Jolla Institute for Immunology

Dr. Matthias von Herrath, M.D., who founded the Type 1 Diabetes Center at La Jolla Institute for Immunology (LJI) has been identified as the world’s top expert in Type 1 Diabetes by Expertscape, an organization that provides tools to quickly and easily find the best clinicians or pioneering scientists specializing in a wide range of medical conditions or biomedical topics.

Released:
12-Dec-2018 11:05 AM EST

Article ID: 705292

The Weizmann Institute of Science Establishes the Dr. Barry Sherman Institute for Medicinal Chemistry

Weizmann Institute of Science

The new Sherman Institute will advance basic research on novel therapies for a range of disorders, including autoimmune, neurodegenerative, and infectious diseases, as well as cancer.

Released:
11-Dec-2018 5:05 PM EST

Article ID: 705285

FSU researchers find racial inequity among adolescents receiving flu vaccine

Florida State University

Black adolescents living in the United States tend to receive the influenza vaccine at significantly lower rates than their white and Hispanic counterparts, according to Florida State University researchers. A new study, led by former FSU graduate student Noah Webb, along with current graduate student Benjamin Dowd-Arrow and Associate Professors of Sociology Miles Taylor and Amy Burdette, was recently published in Public Health Reports.

Released:
11-Dec-2018 4:05 PM EST

Social and Behavioral Sciences

Koenig_360.jpg

Article ID: 705279

How Does Pregnancy Inflammation Affect Immunity in Newborns?

Saint Louis University Medical Center

SLU pediatric researchers received $412,500 from the NIH to study how fetal exposure to inflammation can alter immune responses after birth.

Released:
11-Dec-2018 3:05 PM EST

Article ID: 705277

الباحثون لدى Mayo: أبيكسابان الفموي آمن وفعال لعلاج جلطات مرضى السرطان

Mayo Clinic

سان دييغو —اكتشف الباحثون لدى Mayo Clinic أن العقار الفموي أبيكسابان الذي يُستخدم لعلاج جلطات الدم لدى المرضى الذين يُعالَجون من مرض السرطان علاج آمن وفعال. ولا يقترن ذلك العقار بالكثير من حالات النزيف الحاد أو تكرار الإصابة بجلطات الدم بالمقارنة مع عقار هيبارين ذي الوزن الجزيئي المنخفض. وقد قدّم هذه الاكتشافات لدى الاجتماع السنوي للجمعية الأمريكية لأمراض الدم الدكتور روبرت ماكبين الثاني طبيب أمراض القلب لدى Mayo Clinic.

Released:
11-Dec-2018 3:05 PM EST

Article ID: 705278

الباحثون لدى Mayo Clinic يحددون استراتيجيات جديدة قد تحسن العلاج بالخلايا التائية خيمرية المستضد (CAR-T cell)

Mayo Clinic

سان دييغو — طوّر الباحثون لدى Mayo Clinic استراتيجيتين جديدتين قد تعملا على تحسين أداء العلاج بالخلايا التائية خيمرية المستضد (CAR-T cell therapy) لعلاج السرطان. ويعرض الباحثون نتائج دراستهم ما قبل السريرية في جلسة عام 2018 من الاجتماع السنوي للجمعية الأمريكية لأمراض الدم في سان دييغو.

Released:
11-Dec-2018 3:05 PM EST

Showing results

110 of 1478

Chat now!